cisapride has been researched along with alpha-aminopyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawatsu, R; Kohmura, Y; Toga, T | 1 |
| Cseke, A; Ecker, GF; Montanari, F; Wlcek, K | 1 |
2 other study(ies) available for cisapride and alpha-aminopyridine
| Article | Year |
|---|---|
The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities.
Topics: Aminopyridines; Arrhythmias, Cardiac; Benzamides; Cell Line; Cisapride; Electrophysiology; Ether-A-Go-Go Potassium Channels; Humans; Imidazoles; Inhibitory Concentration 50; Morpholines; Patch-Clamp Techniques; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists | 2007 |
Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors.
Topics: Aminopyridines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzamides; Cell Line, Tumor; Cisapride; Cyclopropanes; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Logistic Models; Neoplasm Proteins; Probability; Reproducibility of Results; ROC Curve; User-Computer Interface | 2017 |